These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 20123462

  • 1. Event-related potential correlates of selective processing in early- and continuously-treated children with phenylketonuria: effects of concurrent phenylalanine level and dietary control.
    de Sonneville LM, Huijbregts SC, van Spronsen FJ, Verkerk PH, Sergeant JA, Licht R.
    Mol Genet Metab; 2010; 99 Suppl 1():S10-7. PubMed ID: 20123462
    [Abstract] [Full Text] [Related]

  • 2. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A, Prevor MB, Callender G, Druin DP.
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria.
    Huijbregts S, de Sonneville L, Licht R, Sergeant J, van Spronsen F.
    Dev Neuropsychol; 2002; 22(2):481-99. PubMed ID: 12537335
    [Abstract] [Full Text] [Related]

  • 4. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
    Anastasoaie V, Kurzius L, Forbes P, Waisbren S.
    Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
    [Abstract] [Full Text] [Related]

  • 5. Visual event-related potentials in children with phenylketonuria.
    Henderson RM, McCulloch DL, Herbert AM, Robinson PH, Taylor MJ.
    Acta Paediatr; 2000 Jan; 89(1):52-7. PubMed ID: 10677058
    [Abstract] [Full Text] [Related]

  • 6. Pre-attentive processing in children with early and continuously-treated PKU. Effects of concurrent Phe level and lifetime dietary control.
    de Sonneville LM, Huijbregts SC, Licht R, Sergeant JA, van Spronsen FJ.
    J Inherit Metab Dis; 2011 Aug; 34(4):953-62. PubMed ID: 21541727
    [Abstract] [Full Text] [Related]

  • 7. Evidence for the importance of dopamine for prefrontal cortex functions early in life.
    Diamond A.
    Philos Trans R Soc Lond B Biol Sci; 1996 Oct 29; 351(1346):1483-93; discussion 1494. PubMed ID: 8941960
    [Abstract] [Full Text] [Related]

  • 8. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J, Fromm J, van Teeffelen-Heithoff A, Möller HE, Koletzko B, Marquardt T, Rutsch F, Feldmann R.
    Mol Genet Metab; 2013 Oct 29; 110 Suppl():S44-8. PubMed ID: 24071437
    [Abstract] [Full Text] [Related]

  • 9. Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level.
    Schmidt E, Rupp A, Burgard P, Pietz J, Weglage J, de Sonneville L.
    J Clin Exp Neuropsychol; 1994 Oct 29; 16(5):681-8. PubMed ID: 7836491
    [Abstract] [Full Text] [Related]

  • 10. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R, Huijbregts SC, de Sonneville LM, van der Meere JJ, Bosch AM, Hollak CE, Rubio-Gozalbo ME, Brouwers MC, Hofstede FC, de Vries MC, Janssen MC, van der Ploeg AT, Langendonk JG, van Spronsen FJ.
    Mol Genet Metab; 2013 Oct 29; 110 Suppl():S57-61. PubMed ID: 24183792
    [Abstract] [Full Text] [Related]

  • 11. Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU).
    Bruinenberg VM, van Vliet D, van der Goot E, Counotte DS, Kuhn M, van Spronsen FJ, van der Zee EA.
    PLoS One; 2019 Oct 29; 14(3):e0213391. PubMed ID: 30875376
    [Abstract] [Full Text] [Related]

  • 12. A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels.
    Sharman R, Sullivan K, Young R, McGill J.
    Dev Neuropsychol; 2010 Oct 29; 35(1):57-65. PubMed ID: 20390592
    [Abstract] [Full Text] [Related]

  • 13. Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria.
    Schmidt E, Burgard P, Rupp A.
    Eur J Pediatr; 1996 Jul 29; 155 Suppl 1():S82-6. PubMed ID: 8828617
    [Abstract] [Full Text] [Related]

  • 14. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria.
    Sharman R, Sullivan K, Young R, McGill J.
    Clin Genet; 2009 Feb 29; 75(2):169-74. PubMed ID: 19215250
    [Abstract] [Full Text] [Related]

  • 15. Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations.
    Huijbregts SC, de Sonneville LM, Licht R, van Spronsen FJ, Verkerk PH, Sergeant JA.
    Neuropsychologia; 2002 Feb 29; 40(1):7-15. PubMed ID: 11595258
    [Abstract] [Full Text] [Related]

  • 16. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
    Trepp R, Muri R, Abgottspon S, Bosanska L, Hochuli M, Slotboom J, Rummel C, Kreis R, Everts R.
    Trials; 2020 Feb 13; 21(1):178. PubMed ID: 32054509
    [Abstract] [Full Text] [Related]

  • 17. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
    Weigel C, Kiener C, Meier N, Schmid P, Rauh M, Rascher W, Knerr I.
    Ann Nutr Metab; 2008 Feb 13; 53(2):91-5. PubMed ID: 18946205
    [Abstract] [Full Text] [Related]

  • 18. Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction.
    Seashore MR, Friedman E, Novelly RA, Bapat V.
    Pediatrics; 1985 Feb 13; 75(2):226-32. PubMed ID: 3969322
    [Abstract] [Full Text] [Related]

  • 19. Executive functioning in children and adolescents with phenylketonuria.
    VanZutphen K, Packman W, Sporri L, Needham M, Morgan C, Weisiger K, Packman S.
    Clin Genet; 2007 Jul 13; 72(1):13-8. PubMed ID: 17594394
    [Abstract] [Full Text] [Related]

  • 20. Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria.
    Schulpis KH, Tsakiris S, Traeger-Synodinos J, Papassotiriou I.
    Clin Biochem; 2005 Mar 13; 38(3):239-42. PubMed ID: 15708545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.